Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia

Future Oncology, Ahead of Print.

Source: Future Oncology - February 6, 2018 Category: Cancer & Oncology Authors: Samuel Luke Hill Andrew Davies Source Type: research